Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of a fixed-dose combination of fimasartan, amlodipine, and rosuvastatin (NCT02995720) sponsored by Bory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Fimasartan/Amlodipine/Rosuvastatin fixed-dose combination (fimasartan; amlodipine; rosuvastatin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension, Hyperlipidemia | Phase 1 | Status: COMPLETED